Summary of opinion: Rystiggo,Rozanolixizumab, 09/11/2023, Positive
Submitted by Anonymous (not verified) on 10 November 2023 - 12:14
Summary of opinion: Rystiggo,Rozanolixizumab, 09/11/2023, Positive
Summary of opinion: Omjjara,momelotinib, 09/11/2023, Positive
Submitted by Anonymous (not verified) on 10 November 2023 - 12:14
Summary of opinion: Omjjara,momelotinib, 09/11/2023, Positive
Opinion/decision on a Paediatric investigation plan (PIP): Pemazyre,pemigatinib, decision type: , therapeutic area: , PIP number: P/0472/2022
Submitted by Anonymous (not verified) on 10 November 2023 - 12:08
Opinion/decision on a Paediatric investigation plan (PIP): Pemazyre,pemigatinib, decision type: , therapeutic area: , PIP number: P/0472/2022
Opinion/decision on a Paediatric investigation plan (PIP): semaglutide, decision type: , therapeutic area: , PIP number: P/0481/2022
Submitted by Anonymous (not verified) on 10 November 2023 - 11:59
Opinion/decision on a Paediatric investigation plan (PIP): semaglutide, decision type: , therapeutic area: , PIP number: P/0481/2022
Opinion/decision on a Paediatric investigation plan (PIP): Gazyvaro,Obinutuzumab, decision type: , therapeutic area: , PIP number: P/0502/2022
Submitted by Anonymous (not verified) on 10 November 2023 - 11:34
Opinion/decision on a Paediatric investigation plan (PIP): Gazyvaro,Obinutuzumab, decision type: , therapeutic area: , PIP number: P/0502/2022
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 2023
Submitted by Anonymous (not verified) on 10 November 2023 - 11:05
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 2023
Summary of opinion: Ayvakyt,avapritinib, 09/11/2023, Positive
Submitted by Anonymous (not verified) on 10 November 2023 - 11:00
Summary of opinion: Ayvakyt,avapritinib, 09/11/2023, Positive
Summary of opinion: Keytruda,pembrolizumab, 09/11/2023, Positive
Submitted by Anonymous (not verified) on 10 November 2023 - 11:00
Summary of opinion: Keytruda,pembrolizumab, 09/11/2023, Positive
Summary of opinion: Veltassa,patiromer, 09/11/2023, Positive
Submitted by Anonymous (not verified) on 10 November 2023 - 11:00
Summary of opinion: Veltassa,patiromer, 09/11/2023, Positive
Summary of opinion: Naveruclif,paclitaxel, 09/11/2023, Positive
Submitted by Anonymous (not verified) on 10 November 2023 - 11:00
Summary of opinion: Naveruclif,paclitaxel, 09/11/2023, Positive